rs41288773

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_194248.3(OTOF):​c.3751T>G​(p.Cys1251Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0211 in 1,613,122 control chromosomes in the GnomAD database, including 403 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 19 hom., cov: 33)
Exomes 𝑓: 0.022 ( 384 hom. )

Consequence

OTOF
NM_194248.3 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.62

Publications

11 publications found
Variant links:
Genes affected
OTOF (HGNC:8515): (otoferlin) Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
OTOF Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 9
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041293204).
BP6
Variant 2-26472632-A-C is Benign according to our data. Variant chr2-26472632-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 48225.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0152 (2317/152342) while in subpopulation NFE AF = 0.0241 (1642/68032). AF 95% confidence interval is 0.0232. There are 19 homozygotes in GnomAd4. There are 1046 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 19 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOFNM_194248.3 linkc.3751T>G p.Cys1251Gly missense_variant Exon 30 of 47 ENST00000272371.7 NP_919224.1 Q9HC10-1
OTOFNM_194323.3 linkc.1493-43T>G intron_variant Intron 12 of 28 ENST00000339598.8 NP_919304.1 Q9HC10-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOFENST00000272371.7 linkc.3751T>G p.Cys1251Gly missense_variant Exon 30 of 47 1 NM_194248.3 ENSP00000272371.2 Q9HC10-1
OTOFENST00000339598.8 linkc.1493-43T>G intron_variant Intron 12 of 28 1 NM_194323.3 ENSP00000344521.3 Q9HC10-2

Frequencies

GnomAD3 genomes
AF:
0.0152
AC:
2319
AN:
152224
Hom.:
19
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00478
Gnomad AMI
AF:
0.00658
Gnomad AMR
AF:
0.0145
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.0158
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0241
Gnomad OTH
AF:
0.0163
GnomAD2 exomes
AF:
0.0157
AC:
3927
AN:
249600
AF XY:
0.0164
show subpopulations
Gnomad AFR exome
AF:
0.00342
Gnomad AMR exome
AF:
0.0102
Gnomad ASJ exome
AF:
0.00600
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0166
Gnomad NFE exome
AF:
0.0248
Gnomad OTH exome
AF:
0.0220
GnomAD4 exome
AF:
0.0217
AC:
31685
AN:
1460780
Hom.:
384
Cov.:
32
AF XY:
0.0213
AC XY:
15512
AN XY:
726668
show subpopulations
African (AFR)
AF:
0.00355
AC:
119
AN:
33478
American (AMR)
AF:
0.0111
AC:
495
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
0.00543
AC:
142
AN:
26132
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39696
South Asian (SAS)
AF:
0.00691
AC:
596
AN:
86238
European-Finnish (FIN)
AF:
0.0176
AC:
928
AN:
52582
Middle Eastern (MID)
AF:
0.0272
AC:
157
AN:
5768
European-Non Finnish (NFE)
AF:
0.0252
AC:
28068
AN:
1111828
Other (OTH)
AF:
0.0195
AC:
1177
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
1613
3227
4840
6454
8067
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1054
2108
3162
4216
5270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0152
AC:
2317
AN:
152342
Hom.:
19
Cov.:
33
AF XY:
0.0140
AC XY:
1046
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.00476
AC:
198
AN:
41584
American (AMR)
AF:
0.0144
AC:
221
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00576
AC:
20
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00497
AC:
24
AN:
4826
European-Finnish (FIN)
AF:
0.0158
AC:
168
AN:
10620
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0241
AC:
1642
AN:
68032
Other (OTH)
AF:
0.0161
AC:
34
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
119
238
356
475
594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0203
Hom.:
94
Bravo
AF:
0.0147
TwinsUK
AF:
0.0245
AC:
91
ALSPAC
AF:
0.0270
AC:
104
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.0198
AC:
170
ExAC
AF:
0.0166
AC:
2013
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.0251
EpiControl
AF:
0.0238

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Nov 12, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

OTOF: BP4, BS1, BS2 -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27766948, 19461658) -

not specified Benign:4
Aug 23, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 09, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cys1251Gly in exon 30 of OTOF: This variant is predicted to be benign based on i ts high frequency in the general population (rs41288773; heterozyogous frequency = 2.5%). -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 9 Benign:2
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

May 02, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.047
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
8.8
DANN
Benign
0.50
DEOGEN2
Benign
0.032
.;T;.;.
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.51
T;T;T;T
MetaRNN
Benign
0.0041
T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.55
.;N;N;.
PhyloP100
1.6
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.21
.;N;N;.
REVEL
Benign
0.21
Sift
Benign
0.39
.;T;T;.
Sift4G
Benign
0.46
.;T;T;.
Polyphen
0.0
.;B;.;B
Vest4
0.17, 0.087
MPC
0.19
ClinPred
0.0030
T
GERP RS
-4.8
Varity_R
0.045
gMVP
0.44
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41288773; hg19: chr2-26695500; API